These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1272 related items for PubMed ID: 29490706

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of Colony-Stimulating Factor 1 Receptor by PLX3397 Prevents Amyloid Beta Pathology and Rescues Dopaminergic Signaling in Aging 5xFAD Mice.
    Son Y, Jeong YJ, Shin NR, Oh SJ, Nam KR, Choi HD, Choi JY, Lee HJ.
    Int J Mol Sci; 2020 Aug 03; 21(15):. PubMed ID: 32756440
    [Abstract] [Full Text] [Related]

  • 5. Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice.
    Dagher NN, Najafi AR, Kayala KM, Elmore MR, White TE, Medeiros R, West BL, Green KN.
    J Neuroinflammation; 2015 Aug 01; 12():139. PubMed ID: 26232154
    [Abstract] [Full Text] [Related]

  • 6. Effects of microglial depletion and TREM2 deficiency on Aβ plaque burden and neuritic plaque tau pathology in 5XFAD mice.
    Delizannis AT, Nonneman A, Tsering W, De Bondt A, Van den Wyngaert I, Zhang B, Meymand E, Olufemi MF, Koivula P, Maimaiti S, Trojanowski JQ, Lee VM, Brunden KR.
    Acta Neuropathol Commun; 2021 Sep 09; 9(1):150. PubMed ID: 34503586
    [Abstract] [Full Text] [Related]

  • 7. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH, Kang S, Son SM, Mook-Jung I.
    Glia; 2016 Dec 09; 64(12):2274-2290. PubMed ID: 27658617
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia.
    Lodder C, Scheyltjens I, Stancu IC, Botella Lucena P, Gutiérrez de Ravé M, Vanherle S, Vanmierlo T, Cremers N, Vanrusselt H, Brône B, Hanseeuw B, Octave JN, Bottelbergs A, Movahedi K, Dewachter I.
    Acta Neuropathol Commun; 2021 Jun 08; 9(1):108. PubMed ID: 34103079
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology.
    Olmos-Alonso A, Schetters ST, Sri S, Askew K, Mancuso R, Vargas-Caballero M, Holscher C, Perry VH, Gomez-Nicola D.
    Brain; 2016 Mar 08; 139(Pt 3):891-907. PubMed ID: 26747862
    [Abstract] [Full Text] [Related]

  • 14. CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer's disease.
    Puntambekar SS, Moutinho M, Lin PB, Jadhav V, Tumbleson-Brink D, Balaji A, Benito MA, Xu G, Oblak A, Lasagna-Reeves CA, Landreth GE, Lamb BT.
    Mol Neurodegener; 2022 Jun 28; 17(1):47. PubMed ID: 35764973
    [Abstract] [Full Text] [Related]

  • 15. Intracellular amyloid and the neuronal origin of Alzheimer neuritic plaques.
    Pensalfini A, Albay R, Rasool S, Wu JW, Hatami A, Arai H, Margol L, Milton S, Poon WW, Corrada MM, Kawas CH, Glabe CG.
    Neurobiol Dis; 2014 Nov 28; 71():53-61. PubMed ID: 25092575
    [Abstract] [Full Text] [Related]

  • 16. [Alzheimer disease: cellular and molecular aspects].
    Octave JN.
    Bull Mem Acad R Med Belg; 2005 Nov 28; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [Abstract] [Full Text] [Related]

  • 17. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model.
    Spangenberg E, Severson PL, Hohsfield LA, Crapser J, Zhang J, Burton EA, Zhang Y, Spevak W, Lin J, Phan NY, Habets G, Rymar A, Tsang G, Walters J, Nespi M, Singh P, Broome S, Ibrahim P, Zhang C, Bollag G, West BL, Green KN.
    Nat Commun; 2019 Aug 21; 10(1):3758. PubMed ID: 31434879
    [Abstract] [Full Text] [Related]

  • 18. Brimapitide Reduced Neuronal Stress Markers and Cognitive Deficits in 5XFAD Transgenic Mice.
    Gourmaud S, Thomas P, Thomasseau S, Tible M, Abadie C, Paquet C, Hugon J.
    J Alzheimers Dis; 2018 Aug 21; 63(2):665-674. PubMed ID: 29660941
    [Abstract] [Full Text] [Related]

  • 19. Partial reduction of microglia does not affect tau pathology in aged mice.
    Bennett RE, Bryant A, Hu M, Robbins AB, Hopp SC, Hyman BT.
    J Neuroinflammation; 2018 Nov 09; 15(1):311. PubMed ID: 30413160
    [Abstract] [Full Text] [Related]

  • 20. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
    Brunner D, Flunkert S, Neddens J, Duller S, Scopes DIC, Treherne JM, Hutter-Paier B.
    Neurosci Lett; 2017 Nov 01; 660():96-102. PubMed ID: 28917978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.